Skip to content
Clinical Trials – home
ItalyBack to Italy

Clinical trials in Pozzuoli

9 clinical trials in Pozzuoli, Italy across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

ItalyOur site in ItalyStudi-Clinici.it(opens in a new tab)
Pozzuoli at a glance
9
clinical trials
  • Not yet recruiting0
  • Paediatric trials0
  • Research sites1
Type of trial
Recruitment status
Quick filters

9 trials in Pozzuoli

Open in trial search
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Aflibercept
  • Sponsor:IRCCS Istituto Nazionale Tumori Fondazione Pascale
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Atezolizumab
  • Sponsor:Consorzio Oncotech
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Panitumumab
  • Sponsor:IRCCS Istituto Nazionale Tumori Fondazione Pascale
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Palbociclib
  • Sponsor:Consorzio Oncotech
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Bevacizumab
  • Sponsor:IRCCS Istituto Nazionale Tumori Fondazione Pascale
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Neratinib
  • Sponsor:Fundacion Grupo Espanol De Investigacion En Cancer De Mama
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Durvalumab
  • Sponsor:AstraZeneca AB
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Cisplatin
  • Sponsor:Merck Sharp & Dohme LLC
Registered drug
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Enzalutamide
  • Sponsor:Merck Sharp & Dohme LLC

Other cities in Italy

The busiest research cities in the country

All 232 cities in Italy

Clinical research in Pozzuoli

What the registry says about research in the country

01 Breast Cancer Research

Innovative clinical studies focusing on triple-negative breast cancer and HER2-positive breast cancer treatments. These trials are evaluating novel combination therapies and management strategies.

  • Metastatic Triple-Negative Cancer Treatment
  • HER2+ Early-Stage Management
  • Hormone Receptor Positive Therapy

Research aims to improve survival rates and reduce treatment side effects through targeted therapeutic approaches.

02 Bladder Cancer Studies

Comprehensive research into muscle invasive bladder cancer treatments, exploring innovative therapeutic combinations and surgical approaches.

  • Alternative Treatments for Cisplatin-Ineligible Patients
  • Perioperative Therapy Evaluation
  • Immunotherapy Combinations

Studies focus on developing effective treatment options for patients who cannot receive standard chemotherapy protocols.

03 Immunotherapy Applications

Advanced research utilizing immunotherapy agents across multiple cancer types, particularly in combination with established treatments.

  • Combined Immunotherapy Approaches
  • Novel Drug Combinations
  • Treatment Tolerance Studies

Investigations aim to enhance treatment efficacy while maintaining patient safety and quality of life.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.